临床药师对一例ABPA患者个体化药学干预与药学监护  

Clinical pharmacists individualized pharmaceutical intervention and pharmaceutical care for a patient with ABPA

作　　者：穆杰 MU Jie(Department of Pharmacy,Tianjin Jizhou District People's Hospital,Tianjin 301900,China)

机构地区：[1]天津市蓟州区人民医院药剂科,天津301900

出　　处：《中国处方药》2023年第1期67-70,共4页Journal of China Prescription Drug

摘　　要：目的临床药师参与一例ABPA患者用药方案的制定与药学监护的过程。方法临床药师通过检索相关文献,结合本病例,分析危险因素,协助医师制定个体化用药方案,并进行药学监护,及时发现不良反应,进行不良反应相关性评价,提出解决方案。结果通过临床药师的个体化药学干预与药学监护,患者预后良好出院。结论临床药师协助医师制定个体化用药方案及药学监护,提高了治疗的安全性和有效性。Objective Clinical pharmacists participated in the formulation of medication regimen and pharmaceutical care of a patient with ABPA.Methods Clinical pharmacists searched relevant literature and analyzed risk factors in combination with this case to assist physicians in formulating individualized drug use plan,and conducted pharmaceutical care,timely detection of adverse reactions,correlation evaluation of adverse reactions,and proposed solutions.Results The patient had a good prognosis and was discharged from hospital through individualized pharmaceutical intervention and pharmaceutical care by clinical pharmacists.Conclusion Clinical pharmacists can improve the safety and effectiveness of treatment by assisting physicians in the formulation of individualized drug regimen and pharmaceutical care.

关 键 词：临床药师 ABPA 药学干预 药学监护 

分 类 号：R969[医药卫生—药理学]